Saturday, October 07, 2023 10:00:51 AM
I've always been a rather doggeded fighter in such matters, but, after 12 years of wittnessing the plays this entity has made (all seemingly in vein if indeed those efforts were meant to succeed at all) I'm sorta out of things to think about or say in regard to LQMT. Truth is that I never owned as many shares as others have indicated that they possess, but, I have wound down that number significantly over the past two years. I"m still in the hole but I'm glad that I'm not ready to jump off the roof. I suppose in some ways I'm progressing though the stages of grief while bobbing up every now and then for some air.
Thanks again for your efforts as they do keep me engaged althoug even if the share price were to go to $.60c I'll not be able to build a vacation home. As for people who are in on this LQMT joke and do indeed know what the joke is exactily I hope that what you are profitting from is worth what you have done to shareholders who have beem rather trusting and gullible, especially when you make one of your announcements that allow us to feed upon. I understand how I could believe that Li's intervention in 2016, TC's prediction of profitability in 2017, the purchase of a building called the "Center of Excellence", Paul Hauck's hire and his training of SLR's, electical upgrades, partnerships with Apple, Engel, Electurlux ( sp ?) etc, etc.,etc, and the cash to provide time to make sales happen all could help me believe. It is just as hard to believe that nothing has come to the American shareholder by way of all these "efforts"
Recent LQMT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 10:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2023 10:26:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 08:41:42 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM